Mechanistic description
ASO-mediated knockdown of ATXN2 reduces repeat-associated non-AUG translation of toxic dipeptide repeat proteins from C9orf72 hexanucleotide expansions. Validated intrathecal ASO platform but undermined by conflicting genetic modifier data and direct competition from BIIB105/ION363.
Mechanism / pathway
- ATXN2
- neurodegeneration
Evidence for (3)
ATXN2 intermediate expansions increase ALS risk
ATXN2 knockdown reduces toxicity in C9orf72 models
ATXN2 interacts with poly(GR) and poly(GA) dipeptide repeat proteins
Evidence against (3)
ATXN2 mutations cause spinocerebellar ataxia type 2 and knockdown may exacerbate dysfunction in patients with ATXN2 polymorphisms
ATXN2 essential for synaptic physiology with complete knockdown causing behavioral abnormalities in mice
Some evidence suggests ATXN2 may be protective modifier in ALS contexts—dual role creates therapeutic ambiguity
Evidence matrix
Supporting
- ATXN2 intermediate expansions increase ALS risk PMID:25966627
- ATXN2 knockdown reduces toxicity in C9orf72 models PMID:31727865
- ATXN2 interacts with poly(GR) and poly(GA) dipeptide repeat proteins PMID:31171694
Contradicting
- ATXN2 mutations cause spinocerebellar ataxia type 2 and knockdown may exacerbate dysfunction in patients with ATXN2 polymorphisms
- ATXN2 essential for synaptic physiology with complete knockdown causing behavioral abnormalities in mice
- Some evidence suggests ATXN2 may be protective modifier in ALS contexts—dual role creates therapeutic ambiguity
Cite this hypothesis
Cite this hypothesis
envelope-repair (2026). ATXN2 Antisense Oligonucleotides Reduce Dipeptide Repeat Proteins in C9orf72-AL…. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-e9db71317e
@misc{scidex_hypothesis_he9db713,
title = {ATXN2 Antisense Oligonucleotides Reduce Dipeptide Repeat Proteins in C9orf72-AL…},
author = {envelope-repair},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-e9db71317e},
note = {SciDEX artifact hypothesis:h-e9db71317e}
}